Advertisement
News
Subscribe to MDT Magazine News

FDA approves first new drug for lupus in 56 years

March 9, 2011 12:45 pm | by The Associated Press | Comments

The Food and Drug Administration has approved the first new drug to treat lupus since 1955, a milestone that medical experts say could prompt development of other drugs that are even more effective in treating the debilitating illness.Known as Benlysta, the injectable drug is designed to treat...

Summary Box: Walgreen sells PBM unit to Catalyst

March 9, 2011 11:45 am | by The Associated Press | Comments

THE DEAL: Walgreen Co. is selling Walgreens Health Initiatives, its pharmacy benefits management business, to Catalyst Health Solutions Inc. for $525 million.THE STRATEGY: The pharmacy benefits unit was not a major part of Walgreen's business compared to its drugstores, but the deal more than...

CSI and alien invaders in Puerto Rico

March 9, 2011 11:37 am | by EurekAlert | Comments

(Entomological Society of America) "CSI Puerto Rico: Adventures in Forensic Entomology" and "Invasive Alien Species in the Caribbean Basin of Concern to the USA" are just two of the symposia that will be presented at a joint meeting between the Southeastern Branch of the...

TOPICS:
Advertisement

Cantel Medical Corp. to Present at The Sidoti & Company LLC Fifteenth Annual Emerging Growth Institutional Investor Forum

March 9, 2011 11:34 am | by Bio-Medicine.Org | Comments

LITTLE FALLS, N.J., March 9, 2011 /- CANTEL MEDICAL CORP. (NYSE: CMN ) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Sidoti & Company, LLC Fifteenth Annual Emerging Growth Institutional Investor Forum. The formal presentation is scheduled for...

TOPICS:

BioTox Sciences (BTS) Deploys eStudyâ„¢ Hosted Solution for Management of GLP & Non-GLP Preclinical Studies

March 9, 2011 9:35 am | by Bio-Medicine.Org | Comments

CARY, N.C., March 9, 2011 /- iAdvantage Software, Inc. , a leading solutions provider for managing development and pre-clinical life science studies, today announced that BioTox Sciences (BTS) , a GLP Contract Research Organization, headquartered in San Diego, California, is deploying the...

TOPICS:

Trinity Biotech plc to Present at the ROTH Capital Partners 23rd Annual OC Growth Stock Conference

March 9, 2011 9:33 am | by Bio-Medicine.Org | Comments

DUBLIN, March 9, 2011 /- Trinity Biotech plc (Nasdaq: TRIB ), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it will present at the ROTH Capital Partners 23rd Annual OC Growth Stock Conference at the...

TOPICS:

ViroPharma board approves $150 million buyback

March 9, 2011 8:45 am | by The Associated Press | Comments

ViroPharma Inc. said Wednesday that its board of directors approved a program to buy back up to $150 million in stock and 2 percent senior convertible notes due 2017.The company had about 78.1 million shares of common stock outstanding as of Dec. 31.Shares of ViroPharma rose 99 cents, or 5.5...

AeroDef Sessions to Show How OEMs, Suppliers Are Creating 'Digital Thread'

March 9, 2011 8:35 am | by Society of Manufacturing Engineers | Comments

Anaheim, March 9, 2011 — The concept of a digital thread — several supply chain partners with different skill sets, systems and processes, working together with OEMs to integrate aerospace and defense manufacturing to a greater degree than has ever been accomplished in the...

Advertisement

Abnormal neural activity recorded from the deep brain of Parkinson's disease and dystonia patients

March 9, 2011 7:36 am | by EurekAlert | Comments

(National Institute for Physiological Sciences) An international joint research team led by Professor Toru Itakura and Assistant Professor Hiroki Nishibayashi from Wakayama Medical University, Japan, Professor Atsushi Nambu from the National Institute for Physiological Sciences,...

TOPICS:

High-volume portable music players may impair ability to clearly discriminate sounds

March 9, 2011 7:35 am | by EurekAlert | Comments

(National Institute for Physiological Sciences) The study was a collaboration between Drs. Hidehiko Okamoto and Ryusuke Kakigi from the National Institute for Physiological Sciences, Japan, and Drs. Christo Pantev and Henning Teismann from the University of Muenster. The...

TOPICS:

Reportlinker Adds Advances in SPECT Imaging (Technical Insights)

March 9, 2011 7:34 am | by Bio-Medicine.Org | Comments

NEW YORK, March 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Advances in SPECT Imaging (Technical Insights) http://www.reportlinker.com/p0443053/Advances-in-SPECT-Imaging-Technical-Insights.html This research service evaluates the...

TOPICS:

University of Wisconsin Carbone Cancer Center to Acquire ViewRay Radiation Therapy System

March 9, 2011 7:33 am | by Bio-Medicine.Org | Comments

CLEVELAND, March 9, 2011 /- The University of Wisconsin Carbone Cancer Center (UWCCC) in Madison, Wisconsin, will soon become one of the first oncology research centers to acquire a radiotherapy system from ViewRay™, Inc., a privately held medical device company. ViewRay's new...

TOPICS:

Consumer Information on: Selenia Dimensions 3D System - P080003

March 9, 2011 6:36 am | by U.S. Food & Drug Administration | Comments

The Selenia Dimensions 3D System is comprised of hardware and software upgrades to the Selenia Dimensions 2D full-field digital mammography system, which is FDA approved for conventional mammography. The hardware upgrades produces multiple, low-dose x-ray

Summary Information for: Selenia Dimensions 3D System

March 9, 2011 6:36 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Selenia Dimensions 3D System (P080003).

Hospira Announces U.S. Approval of Generic Docetaxel

March 9, 2011 6:34 am | by Bio-Medicine.Org | Comments

LAKE FOREST, Ill., March 9, 2011 /- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of docetaxel. The medication is a generic version of Sanofi-Aventis's Taxotere®, and Hospira...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading